Table of Contents

All the data and content are powered by ZXData, Learn more about ZXData

ZX Data private stock trade

Executive Summary

  • This quarter, reporting holders marked up their private portfolios by 4.0% ($ weighted) with an average mark-down of 1.6% (equal weighted).
  • Sentiment up:
  • Sentiment down:
  • In October, 23% of companies with ZX Index Values showed a difference of 10% or less compared to Fund Marks, and 49% of companies with ZX Index Values showed a difference of 20% or less compared to Fund Marks.

Heat Map: August 31st, 2024 Reporting Period

4.0%

Appreciation/Depreciation of All Reported Holdings1

-1.6%

Average Mark-Up/Mark-Down Across All Reported Holdings2
Dragonfly Therapeutics
98.2%
Diamond Foundry
23.7%
Caris
22.0%
Chime
22.0%
MNTN
20.5%
Lime
19.9%
Tenstorrent
18.5%
Bolt
16.6%
Pine Labs
16.3%
SpaceX
15.5%
Jumo
14.0%
Klarna
13.9%
Dataminr
13.2%
Lightmatter
12.7%
Castle Creek
10.7%
EndeavorBio
10.1%
Generate Bio
10.0%
Genesis Therapeutics
8.4%
Wugen
8.3%
Xsight Labs
8.3%
Evozyne
7.7%
Odyssey Therapeutics
7.5%
Kartos Therapeutics
7.3%
ElevateBio
7.2%
Skyhawk
6.7%
Freenome
6.2%
PsiQuantum
6.1%
Tanium
6.1%
Roofstock
6.0%
AgomAb Therapeutics
5.9%
Stripe
5.8%
Goop
5.7%
Caidya (dMed)
5.5%
Deep Genomics
5.5%
Ankyra
5.4%
Element Bio
5.3%
Lenskart
5.3%
LifeMine
5.1%
Moloco
4.9%
SalioGen
4.9%
Skyryse
4.6%
Scorpion Therapeutics
4.3%
VideoAmp
4.3%
Kardium
4.2%
A24 Films
3.8%
Starling Bank
3.1%
Blink Health
1.7%
Fanatics
1.6%
Medical Micro
1.5%
Clio
1.4%
Rappi
1.4%
Alif Semi
1.3%
Canva
1.1%
Cleerly
1.0%
VAST Data
0.9%
Saluda Medical
0.8%
Retym
0.7%
FLEXE
0.5%
Aledade
0.4%
Druva
0.4%
Inscripta
0.4%
Sonoma Bio
0.4%
Waymo
0.4%
Bright Peak
0.3%
Conformal Medical
0.3%
FogPharma
0.3%
Redwood Materials
0.3%
Honor Tech
0.2%
Seismic
0.2%
Unqork
0.2%
Cellanome
0.1%
Cross River
0.1%
Epic Games
0.1%
ServiceTitan
0.1%
Treeline Bio
0.1%
Algolia
0.0%
Altos Labs
0.0%
Anthropic
0.0%
Bombas
0.0%
Bowery
0.0%
Celonis
0.0%
Discord
0.0%
Epirus
0.0%
Fabletics
0.0%
Faraday Pharma
0.0%
Figma
0.0%
Galvanize
0.0%
Grammarly
0.0%
Gusto
0.0%
Heal
0.0%
Insitro
0.0%
KoBold Metals
0.0%
Magic Leap
0.0%
Menlo Micro
0.0%
Mirador Therapeutics
0.0%
Quell
0.0%
Rapyd
0.0%
RefleXion Medical
0.0%
Snyk
0.0%
Tarana
0.0%
x.AI
0.0%
BETA Technologies
-0.1%
Astranis
-0.2%
SecurityScorecard
-0.2%
Ant Group
-0.6%
Meesho
-0.8%
CoreWeave
-2.0%
Adimab
-2.4%
SiMa ai
-2.7%
Circle
-3.0%
Relativity Space
-3.4%
Sila Nano
-3.6%
Tory Burch
-4.4%
Laronde
-4.8%
Farmers Business Network
-5.0%
JUUL
-5.2%
Omada Health
-5.2%
ABL Space
-5.7%
Asimov
-5.7%
Databricks
-6.3%
Bytedance
-6.6%
Savage X
-6.6%
Airtable
-7.2%
Color Genomics
-7.5%
MasterClass
-8.6%
Signifyd
-8.9%
GupShup
-9.9%
DNA Script
-10.5%
Thriveworks
-10.5%
Checkr
-10.9%
Arctic Wolf
-11.0%
GOAT
-11.0%
Resilience
-12.0%
CelLink
-12.8%
Nuro
-12.9%
Liquid Death
-14.5%
Einride
-15.0%
DataRobot
-15.2%
Verily
-15.3%
Locus Robotics
-15.9%
goPuff
-17.1%
SambaNova
-18.7%
Enevate
-18.9%
Tipalti
-21.9%
Asapp
-26.2%
X Holdings
-26.8%
YuLife
-29.8%
Socure
-33.4%
HaulHub
-37.0%
AgBiome
-40.1%
Rad Power
-45.3%
T-Knife
-62.9%
PrognomIQ
-98.6%

1 Dollar-weighted return on all reported holdings
2 Equal-weighted mark-up or mark-down across all reported holdings

This quarter, reporting holders marked up their private portfolios by 4.0% ($ weighted) with an average mark-down of 1.6% (equal weighted). The period saw three advancing companies for every five declining companies.

Dragonfly Therapeutics experienced the most significant mark-up, followed by Diamond Foundry, Chime and Caris. CleanTech, Aerospace & Defense and Semiconductors saw the largest mark-ups across sectors.

PrognomIQ saw the largest mark-down followed by T-Knife, Rad Power and AgBiome. Among sectors, AgTech, EdTech and SaaS saw the largest mark-downs.

Comparison of ZX Index Value vs. Fund Marks

CompaniesRobustness Score3ZX Index Values4 vs. Fund Marks
GOAT2+461.70%
Lightmatter7+206.60%
Asapp1+201.20%
MasterClass1+192.20%
Lime2+140.70%
Sila Nano1+81.70%
Checkr1+62.90%
Redwood Materials6+53.70%
Socure1+44.50%
Anthropic8+38.80%
CoreWeave8+27.40%
Figma7+26.30%
Meesho1+23.50%
Anduril8+22.70%
x.AI7+19.60%
GupShup1+17.20%
Epirus1+17.00%
Stripe6+16.60%
Canva5+16.50%
Airtable4+13.80%
Bolt6+12.50%
Einride1+7.30%
Relativity Space4+6.90%
Databricks8+4.90%
SpaceX8+4.30%
Moloco1+4.00%
Tanium1+3.90%
VAST Data3-0.90%
DataRobot2-2.50%
Aledade2-2.70%
Waymo2-2.80%
Omada Health4-5.00%
Cross River1-6.10%
Chime7-8.80%
ServiceTitan6-10.00%
Arctic Wolf6-11.50%
Discord5-13.70%
Dataminr4-15.40%
Locus Robotics2-16.90%
Freenome1-17.70%
Gusto5-18.50%
Tenstorrent5-20.00%
Altos Labs2-20.10%
JUUL1-20.20%
Klarna8-21.50%
KoBold Metals2-22.20%
Algolia6-25.60%
Celonis2-26.00%
Liquid Death6-28.20%
Epic Games4-30.50%
SambaNova6-31.10%
Rapyd4-31.70%
Zipline1-36.30%
Bytedance6-36.90%
Fanatics5-37.10%
Circle5-40.60%
Snyk5-44.00%

3 ZXData Robustness Score is an internally developed metric to assign confidence levels to the underlying data used in constructing ZXData output metrics. The ZXData Robustness Score is calculated on a scale of 1 to 10 for each company, based on the number of executed trades, number of buy and sell orders submitted to ZX and skewness of the order book.
4 ZX Index Value is an internally developed metric that reflects secondary values for private companies using an algorithmic approach based on the values sourced from ZX and ZXData partners. The algorithm used to calculate ZX Index Values incorporates both executed transaction values and bid and ask pricing.

In October, 23% of companies with ZX Index Values showed a difference of 10% or less compared to Fund Marks, and 49% of companies with ZX Index Values showed a difference of 20% or less compared to Fund Marks. Among the companies, GOAT, Lightmatter and Asapp had the highest positive variance in reported marks versus ZX Index Values. Snyk, Circle and Fanatics had the highest negative variance in reported marks versus ZX Index Values.

Highest Variance in Reported Marks
CompanyNormalized Std Dev5$ Weighted AvgMaxMin
AgBiome.93$0.05$0.10$0.00
PrognomIQ.53$0.19$0.25$0.03
Rad Power.45$0.40$0.61$0.20
DNA Script.33$281.94$324.85$77.16
Grammarly.29$19.10$29.19$15.97

5 Normalized Standard Deviation is used to express the measure of spread across reported marks and allows for comparison between companies independent of their price per share based on a dollar-weighted average.

This period, AgBiome ($0.00 - $0.10) saw the highest share price variance across funds followed by PrognomIQ ($0.03 - $0.25) and Rad Power ($0.20 - $0.61).

Positive Trend Reversal6 (# = consecutive prior qtrs marked down or flat)
Negative Trend Reversal7 (# = consecutive prior qtrs marked up or flat)
Positive Trend Reversal6 (# = consecutive prior qtrs marked down or flat)
Goop
9
Dataminr
7
Caris
6
Aledade, Diamond Foundry, Element Bio, Epic Games, Kardium
5
Negative Trend Reversal7 (# = consecutive prior qtrs marked up or flat)
Arctic Wolf
4
Omada Health
4
PsiQuantum
4
Relativity Space, Tory Burch
4

6 Positive Trend Reversal reflects an individual holding marked up after consecutive quarterly periods marked down or flat
7 Negative Trend Reversal reflects an individual holding marked down after consecutive quarterly periods marked up or flat

Goop saw its first positive reversal in nine quarters while Dataminr saw its first positive reversal in seven quarters. Arctic Wolf, Omada Health, PsiQuantum, Relativity Space and Tory Burch all saw their first negative reversals in four quarters.

Disclaimer

This report is based on data reported by 300+ funds and $56+ billion of value. Many holders of private company shares do not report their holding values and are thus not included in this report’s dataset. Further, many venture-backed private companies are not held by any reporting funds and are thus not included in this report. As such, this report should not be construed as providing a complete picture of shareholder sentiment or venture-backed private company performance. This report does not constitute investment advice or a "research report" as defined by FINRA Rules.

The “ZX Index Value” is derived by applying proprietary weightings to the order flow data collected for the stated period (both bids and asks), based on the order type (firm order or indication of interest) and whether the order has been executed, with greater weight given to more recent orders.

Zanbato, Inc. (“Zanbato”) prepares and disseminates market information about venture-backed private company securities, and the current bids and offers for those securities listed on the ATS operated by Zanbato (“ZX”). The information provided in this report has been prepared by sales, trading, or other non-research functions. Pricing indications and macro commentary are provided for information purposes only. This report is not intended to assess the individual merits of a particular investment or strategy, does not constitute a recommendation to buy or sell any financial instrument or to participate in any trading strategy and should not be construed as such. This report does not constitute investment advice. Certain information in this report has been obtained from third party sources and, while such information is believed by Zanbato to be reliable, it has not been independently verified by Zanbato and Zanbato shall not be responsible or liable, directly or indirectly, for any damage or loss caused or alleged to be caused by or in connection with any use of, or reliance on, such third party information. Furthermore, the information contained in this report may not be current due to, among other things, changes in the financial markets or economic environment. Zanbato does not, and has no obligation to, update any such information contained in this report. Any prices or quotations contained herein are indicative only, do not represent firm quotes as to either price or size and should not be used for valuation purposes.

yukacon_arrow_up_right